PAHO selects centers in Argentina, Brazil to develop COVID-19 mRNA vaccinesMiguel Martínez-Cava2022-01-19T13:58:04+01:00October 25, 2021|News|
European Commission Approves mAbxience’s Bevacizumab For The Treatment Of Certain Types Of CancerMiguel Martínez-Cava2021-03-31T09:41:47+02:00March 31, 2021|News|
Spain’s mAbxience boosting biologics capacity with 4,000 L SUBMiguel Martínez-Cava2021-03-25T19:20:27+01:00March 25, 2021|News|